Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot Study of Venlafaxine for Depression Associated with Rheumatoid Arthritis
2004-002482-20Phase 4Terminated
- Sponsor
- Newcastle Hospitals NHS Foundation Trust
- Start
- Feb 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of venlafaxine in major depressive disorder (MDD) and rheumatoid arthritis (RA), sponsored by Newcastle Hospitals NHS Foundation Trust. Primary endpoint: Prevalence and severity of depression in rheumatoid arthritis population. Started Feb 2005; status: terminated.
02
Drugs
venlafaxine
03
Conditions
major depressive disorder (MDD)rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2004-002482-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-002482-20.